GWM
CNMD icon

Geneos Wealth Management’s CONMED CNMD Stock Holding History

Geneos Wealth Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26
Closed -$1.35K – 2626
2025
Q2 		$1.35K Sell
26
-5
-16% -$274 ﹤0.01% 2903
2025
Q1 		$4.95K Buy
31
+21
+210% +$1.35K ﹤0.01% 2751
2024
Q4 		$684 Hold
10
– – ﹤0.01% 2843
2024
Q3 		$719 Buy
+10
New +$706 ﹤0.01% 2504
2024
Q2 		– Sell
-13
Closed -$1.04K – 2081
2024
Q1 		$1.04K Buy
+13
New +$1.16K ﹤0.01% 2013

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geneos Wealth Management's CNMD Position: Q3 2025 in Review

Geneos Wealth Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 26 shares — an estimated $1.35K sold.

Geneos Wealth Management first reported a position in CNMD in Q1 2024 and held it in 5 quarters. The position peaked at $4.95K in Q1 2025. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • Geneos Wealth Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 26 CONMED shares in Q3 2025, an estimated $1.35K.
  • Geneos Wealth Management first reported a position in CONMED in Q1 2024 and held it in 5 quarters.
  • Geneos Wealth Management's CONMED position peaked at $4.95K in Q1 2025.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.